Home / Patients Family / Academy / Digital Academy

Digital Academy


Dr. Lauren Wood, director of neuromuscular research in the rare disease research unit at Pfizer, Inc., presents an overview of the progress achieved in DM1 drug development at Pfizer to date, and anticipated next steps for clinical trial development – at the 2016 MDF Annual Conference.


Drs. John Day, M.D., Ph.D, of Stanford University, Chad Heatwole, M.D., of the University of Rochester and Giovanni Meola, M.D., of the University of Milan present an overview of DM-related disease impacts and symptoms, and the current status of brain-related DM research – at the 2016 MDF Annual Conference.


MDF Chief Executive Officer Molly White provides a look back at the first 10 years of MDF programming and research progress, and the significant accomplishments achieved – at the 2016 MDF Annual Conference.


Dr. Cynthia Gagnon, Ph.D., a professor and member of the interdisciplinary research group on neuromuscular disorders at the University of Sherbrooke in Quebec, CA.


Dr. Karen Blakemore, M.D., director of prenatal genetics at the Prenatal Diagnostic Center in the Johns Hopkins Department of Gynecology and Obstetrics, Julie Cohen, certified genetic counselor in the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute, and Alice Schindler, MS, genetic counselor at the National Institutes of Neurological Disorders and Stroke (NINDS), provide a comprehensive overview of family planning strategies and considerations for families living with myotonic dystrophy – at the 2016 MDF Annual Conference.


© Myotonic Dystrophy Foundation. All rights reserved.